Logo image of AXTA

AXALTA COATING SYSTEMS LTD (AXTA) Stock Fundamental Analysis

NYSE:AXTA - New York Stock Exchange, Inc. - BMG0750C1082 - Common Stock - Currency: USD

30.87  -0.37 (-1.18%)

After market: 30.87 0 (0%)

Fundamental Rating

6

AXTA gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. While AXTA belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. AXTA scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make AXTA a good candidate for value investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year AXTA was profitable.
In the past year AXTA had a positive cash flow from operations.
Each year in the past 5 years AXTA has been profitable.
In the past 5 years AXTA always reported a positive cash flow from operatings.
AXTA Yearly Net Income VS EBIT VS OCF VS FCFAXTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 6.06%, AXTA belongs to the top of the industry, outperforming 84.71% of the companies in the same industry.
With an excellent Return On Equity value of 21.63%, AXTA belongs to the best of the industry, outperforming 90.59% of the companies in the same industry.
The Return On Invested Capital of AXTA (10.48%) is better than 85.88% of its industry peers.
AXTA had an Average Return On Invested Capital over the past 3 years of 7.99%. This is in line with the industry average of 6.84%.
The last Return On Invested Capital (10.48%) for AXTA is above the 3 year average (7.99%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.06%
ROE 21.63%
ROIC 10.48%
ROA(3y)3.93%
ROA(5y)3.43%
ROE(3y)16.37%
ROE(5y)15.06%
ROIC(3y)7.99%
ROIC(5y)7.07%
AXTA Yearly ROA, ROE, ROICAXTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

With an excellent Profit Margin value of 8.56%, AXTA belongs to the best of the industry, outperforming 81.18% of the companies in the same industry.
AXTA's Profit Margin has improved in the last couple of years.
AXTA has a better Operating Margin (15.73%) than 78.82% of its industry peers.
AXTA's Operating Margin has improved in the last couple of years.
AXTA's Gross Margin of 34.36% is fine compared to the rest of the industry. AXTA outperforms 68.24% of its industry peers.
AXTA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 15.73%
PM (TTM) 8.56%
GM 34.36%
OM growth 3Y8.8%
OM growth 5Y3.79%
PM growth 3Y7.44%
PM growth 5Y5.93%
GM growth 3Y1.74%
GM growth 5Y-0.48%
AXTA Yearly Profit, Operating, Gross MarginsAXTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

AXTA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for AXTA has been reduced compared to 1 year ago.
Compared to 5 years ago, AXTA has less shares outstanding
The debt/assets ratio for AXTA has been reduced compared to a year ago.
AXTA Yearly Shares OutstandingAXTA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
AXTA Yearly Total Debt VS Total AssetsAXTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

AXTA has an Altman-Z score of 2.41. This is not the best score and indicates that AXTA is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of AXTA (2.41) is better than 65.88% of its industry peers.
The Debt to FCF ratio of AXTA is 8.40, which is on the high side as it means it would take AXTA, 8.40 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AXTA (8.40) is better than 67.06% of its industry peers.
A Debt/Equity ratio of 1.64 is on the high side and indicates that AXTA has dependencies on debt financing.
AXTA has a Debt to Equity ratio of 1.64. This is amonst the worse of the industry: AXTA underperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 8.4
Altman-Z 2.41
ROIC/WACC1.22
WACC8.56%
AXTA Yearly LT Debt VS Equity VS FCFAXTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 2.12 indicates that AXTA has no problem at all paying its short term obligations.
AXTA has a Current ratio (2.12) which is comparable to the rest of the industry.
AXTA has a Quick Ratio of 1.53. This is a normal value and indicates that AXTA is financially healthy and should not expect problems in meeting its short term obligations.
AXTA has a Quick ratio of 1.53. This is in the better half of the industry: AXTA outperforms 67.06% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.53
AXTA Yearly Current Assets VS Current LiabilitesAXTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

5

3. Growth

3.1 Past

AXTA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.43%, which is quite impressive.
The Earnings Per Share has been growing slightly by 4.47% on average over the past years.
The Revenue has been growing slightly by 0.96% in the past year.
The Revenue has been growing slightly by 3.31% on average over the past years.
EPS 1Y (TTM)37.43%
EPS 3Y10.28%
EPS 5Y4.47%
EPS Q2Q%22.92%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y6.11%
Revenue growth 5Y3.31%
Sales Q2Q%-2.47%

3.2 Future

The Earnings Per Share is expected to grow by 10.63% on average over the next years. This is quite good.
Based on estimates for the next years, AXTA will show a small growth in Revenue. The Revenue will grow by 1.58% on average per year.
EPS Next Y14.86%
EPS Next 2Y12.55%
EPS Next 3Y11.99%
EPS Next 5Y10.63%
Revenue Next Year0.43%
Revenue Next 2Y1.93%
Revenue Next 3Y2.36%
Revenue Next 5Y1.58%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AXTA Yearly Revenue VS EstimatesAXTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
AXTA Yearly EPS VS EstimatesAXTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

AXTA is valuated correctly with a Price/Earnings ratio of 13.14.
Based on the Price/Earnings ratio, AXTA is valued a bit cheaper than 77.65% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.45, AXTA is valued rather cheaply.
The Price/Forward Earnings ratio is 10.88, which indicates a very decent valuation of AXTA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXTA indicates a somewhat cheap valuation: AXTA is cheaper than 74.12% of the companies listed in the same industry.
AXTA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.90.
Industry RankSector Rank
PE 13.14
Fwd PE 10.88
AXTA Price Earnings VS Forward Price EarningsAXTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AXTA indicates a somewhat cheap valuation: AXTA is cheaper than 67.06% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXTA indicates a somewhat cheap valuation: AXTA is cheaper than 76.47% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.58
EV/EBITDA 8.66
AXTA Per share dataAXTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AXTA has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)0.88
PEG (5Y)2.94
EPS Next 2Y12.55%
EPS Next 3Y11.99%

0

5. Dividend

5.1 Amount

AXTA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AXALTA COATING SYSTEMS LTD

NYSE:AXTA (7/3/2025, 7:03:40 PM)

After market: 30.87 0 (0%)

30.87

-0.37 (-1.18%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)07-30 2025-07-30/amc
Inst Owners102.53%
Inst Owner Change3.08%
Ins Owners0.28%
Ins Owner Change5.8%
Market Cap6.75B
Analysts77.78
Price Target41.17 (33.37%)
Short Float %2.57%
Short Ratio2.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.72%
Min EPS beat(2)6.38%
Max EPS beat(2)15.06%
EPS beat(4)4
Avg EPS beat(4)10.9%
Min EPS beat(4)6.38%
Max EPS beat(4)15.06%
EPS beat(8)6
Avg EPS beat(8)7.65%
EPS beat(12)9
Avg EPS beat(12)6.43%
EPS beat(16)12
Avg EPS beat(16)6.55%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-4.18%
Max Revenue beat(2)-1.58%
Revenue beat(4)0
Avg Revenue beat(4)-2.27%
Min Revenue beat(4)-4.18%
Max Revenue beat(4)-1.17%
Revenue beat(8)0
Avg Revenue beat(8)-2.27%
Revenue beat(12)2
Avg Revenue beat(12)-1.59%
Revenue beat(16)4
Avg Revenue beat(16)-1.15%
PT rev (1m)-1.86%
PT rev (3m)-7.8%
EPS NQ rev (1m)0.08%
EPS NQ rev (3m)-6.4%
EPS NY rev (1m)-0.13%
EPS NY rev (3m)-0.49%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.79%
Revenue NY rev (1m)-0.13%
Revenue NY rev (3m)-1.35%
Valuation
Industry RankSector Rank
PE 13.14
Fwd PE 10.88
P/S 1.29
P/FCF 16.58
P/OCF 11.88
P/B 3.25
P/tB N/A
EV/EBITDA 8.66
EPS(TTM)2.35
EY7.61%
EPS(NY)2.84
Fwd EY9.19%
FCF(TTM)1.86
FCFY6.03%
OCF(TTM)2.6
OCFY8.42%
SpS23.99
BVpS9.5
TBVpS-3.42
PEG (NY)0.88
PEG (5Y)2.94
Profitability
Industry RankSector Rank
ROA 6.06%
ROE 21.63%
ROCE 13.57%
ROIC 10.48%
ROICexc 11.57%
ROICexgc 23.73%
OM 15.73%
PM (TTM) 8.56%
GM 34.36%
FCFM 7.76%
ROA(3y)3.93%
ROA(5y)3.43%
ROE(3y)16.37%
ROE(5y)15.06%
ROIC(3y)7.99%
ROIC(5y)7.07%
ROICexc(3y)8.98%
ROICexc(5y)8.17%
ROICexgc(3y)18.89%
ROICexgc(5y)17.47%
ROCE(3y)10.36%
ROCE(5y)9.19%
ROICexcg growth 3Y10.83%
ROICexcg growth 5Y5.46%
ROICexc growth 3Y13.92%
ROICexc growth 5Y4.88%
OM growth 3Y8.8%
OM growth 5Y3.79%
PM growth 3Y7.44%
PM growth 5Y5.93%
GM growth 3Y1.74%
GM growth 5Y-0.48%
F-Score8
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.64
Debt/FCF 8.4
Debt/EBITDA 3.07
Cap/Depr 57.09%
Cap/Sales 3.07%
Interest Coverage 250
Cash Conversion 51.31%
Profit Quality 90.65%
Current Ratio 2.12
Quick Ratio 1.53
Altman-Z 2.41
F-Score8
WACC8.56%
ROIC/WACC1.22
Cap/Depr(3y)49.94%
Cap/Depr(5y)42.77%
Cap/Sales(3y)2.8%
Cap/Sales(5y)2.67%
Profit Quality(3y)116.56%
Profit Quality(5y)173.32%
High Growth Momentum
Growth
EPS 1Y (TTM)37.43%
EPS 3Y10.28%
EPS 5Y4.47%
EPS Q2Q%22.92%
EPS Next Y14.86%
EPS Next 2Y12.55%
EPS Next 3Y11.99%
EPS Next 5Y10.63%
Revenue 1Y (TTM)0.96%
Revenue growth 3Y6.11%
Revenue growth 5Y3.31%
Sales Q2Q%-2.47%
Revenue Next Year0.43%
Revenue Next 2Y1.93%
Revenue Next 3Y2.36%
Revenue Next 5Y1.58%
EBIT growth 1Y40.4%
EBIT growth 3Y15.45%
EBIT growth 5Y7.24%
EBIT Next Year37.35%
EBIT Next 3Y15.1%
EBIT Next 5Y11.01%
FCF growth 1Y199.05%
FCF growth 3Y-0.08%
FCF growth 5Y-1.09%
OCF growth 1Y98.67%
OCF growth 3Y1.03%
OCF growth 5Y0.1%